Q1 2025 GE Healthcare Technologies Inc Earnings Call Transcript
Key Points
- GE HealthCare Technologies Inc (GEHC) reported strong revenue and profit growth in the first quarter of 2025, exceeding expectations.
- The company achieved record double-digit orders growth, particularly driven by the US market with a focus on cardiology and oncology imaging products.
- GEHC delivered a robust organic orders growth of 10% year over year, the highest since its spin-off, reflecting healthy market demand.
- The company reported an adjusted EBIT margin of 15%, up 30 basis points year over year, due to volume and productivity improvements.
- GEHC announced a $1 billion share repurchase program, demonstrating confidence in its financial position and commitment to returning cash to shareholders.
- GEHC adjusted its 2025 guidance due to the estimated impact of tariffs on profit and cash, with a significant $0.85 per share impact expected.
- The company expects a decline in adjusted EPS for the full year 2025, representing a 9% to 13% decrease year over year.
- Free cash flow guidance for 2025 was lowered to at least $1.2 billion, down from the previous expectation of at least $1.75 billion, primarily due to tariff payments.
- The adjusted EBIT margin forecast for the full year was reduced to a range of 14.2% to 14.4%, down from the previous guidance of 16.7% to 16.8%.
- GEHC anticipates a low single-digit decline in China's sales performance for 2025, with negative performance expected in the first half of the year.
Good day, and thank you for standing by. Welcome to the GE Healthcare first-quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. (Operator Instructions)
Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Carolynne Borders. Please go ahead.
Thanks, operator. Good morning and welcome to GE Healthcare's first-quarter 2025 earnings call. I'm joined by our President and CEO, Peter Arduini; and Vice President and CFO, James Saccaro.
Our conference call remarks will include both GAAP and non-GAAP financial results. Reconciliations between GAAP and non-GAAP measures can be found in today's press release and in the presentation slides available on our website. During this call, we'll make forward-looking statements about our performance. These statements are based on how we see things today. As described in our SEC filings, actual results may differ
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
